Changes in Hong Kong stocks | Elken Healthcare (01789) rose nearly 6%, and the robotic joint surgery system was recently approved for listing
Elken Healthcare (01789) rose nearly 6%. As of press release, it was up 5.77% to HK$5.5, with a turnover of HK$9.2641 million.
Changes in Hong Kong stocks | Elken Healthcare (01789) is now up more than 5% and the registration certificate for three types of medical devices for knee surgery navigation and positioning systems has been approved
Elken Healthcare (01789) is now up more than 5%. As of press release, it is up 5.4% to HK$5.27, with a turnover of HK$16.797,900.
AK Medical Holdings' Surgical Robot Gets NMPA's Nod
AK Medical Holdings (HKG:1789) said the National Medical Products Administration (NMPA) certified its Knee Surgery Navigation and Positioning System as a class III medical device, according to a Frida
Elken Medical (01789.HK) Knee Surgery Navigation and Positioning System Class III Medical Device Registration Certificate Approved
Gelonghui, April 19, 丨 Elken Medical (01789.HK) announced that the company's registration certificate for the third class of medical devices for knee surgery navigation and positioning systems was approved by the China National Drug Administration on April 17, 2024. The knee navigation and positioning system approved by the company this time consists of a robotic arm truck, an optical navigator, a trolley, control equipment and accessories. The robotic system guides knee osteotomy, soft tissue balance, and prosthetic implantation in real time during surgery. The robotic arm guides knee osteotomy, soft tissue balance, and prosthesis implantation in real time during surgery, bringing more accurate and reliable results to the operation and a better operation experience for doctors
Elken Healthcare (01789.HK): Gao Wei will be appointed as an independent non-executive director
Gelonghui, April 18 | Elken Healthcare (01789.HK) announced the following changes: 1. Eric Wang will retire as an independent non-executive director, effective from the end date of the 2024 Annual General Meeting of Shareholders; 2. Subject to approval by the company's shareholders at the 2024 Annual General Meeting of Shareholders, Gao Wei will be appointed as an independent non-executive director, effective from the end date of the 2024 Annual General Meeting of Shareholders.
Elken Healthcare (1789.HK): Focus on R&D+Actively Go Overseas to Start a New Journey in the Post-Harvesting Era
Core view: Focus on R&D and active overseas, and embark on a new journey in the post-collection era. 1) At present, all three segments of orthopedics have been collected. According to the order of collection and implementation and price reduction, the joint industry affected by collection is relatively fast. presently
Elken Medical (01789.HK): Vigorously expand overseas markets with digital orthopedic technology as the lead
Revenue increased slightly in 2023, and spinal and trauma implants were released rapidly. Achieved revenue of $1,094 million (+4.0%) in 2023, net profit attributable to mother of $182 million (-11.1%); of these, revenue was realized in the second half of the year4
Elken Healthcare (01789.HK): The company's performance is in line with expectations and is optimistic about subsequent joint collection
Core view: The company's performance is in line with expectations. According to the company's 23-year results announcement, the company achieved overall revenue of 1,094 million yuan (YOY +4%) and net profit to mother of 182 million yuan (YOY -11.1%) in '23.
Analysts Offer Insights on Healthcare Companies: Calliditas Therapeutics (CALT), AK Medical Holdings Ltd. (HK:1789) and Consun Pharmaceutical Group Ltd. (Frankfurt: DE:C1P)
AK Medical Holdings Limited Just Missed EPS By 29%: Here's What Analysts Think Will Happen Next
It's shaping up to be a tough period for AK Medical Holdings Limited (HKG:1789), which a week ago released some disappointing yearly results that could have a notable impact on how the market views th
Elken Healthcare (1789.HK): External disturbances affect performance and growth is expected to pick up in 2024
Maintain an increase in holdings rating. Considering the impact of 2023H2 external disturbances on the company's business development pace, the 2024-2025 EPS forecast was reduced to 0.23/0.33 yuan (originally 0.32/0.41 yuan)
Elken Healthcare (1789.HK): Forging ahead for 23 years, optimistic about recovery+contract renewal
Moving forward in 2023, optimistic that 2024 surgery recovery+contract renewal will boost the company's revenue of 1,094 million yuan (+4% yoy) in 2023, and net profit of 182 million yuan (-11.1% yoy) to mother
AK MEDICAL To Go Ex-Dividend On June 24th, 2024 With 0.045 HKD Dividend Per Share
March 27th - $AK MEDICAL(01789.HK)$ is trading ex-dividend on June 24th, 2024. Shareholders of record on June 25th, 2024 will receive 0.045 HKD dividend per share on July 18th, 2024. The ex-divide
Changes in Hong Kong stocks | Medical device stocks rose higher in the afternoon, and mining affected the industry's high-value consumables business growth expectations this year generally improved
Medical device stocks rose in the afternoon. As of press release, Weigao shares (01066) rose 9.25% to HK$5.08; Elken Healthcare (01,789) rose 4.35% to HK$4.08; and minimally invasive robot-B (02252) rose 1.91% to HK$13.88.
Elken Healthcare (01789) will pay a final dividend of HK$0.045 per share on July 18
Elken Healthcare (01789) announced that the company will distribute until 2024 July 18, 2023...
AK MEDICAL: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
Elken Healthcare (01789.HK): Tan Sihui appointed as agent in legal proceedings
On March 26, Ge Longhui | Elken Healthcare (01789.HK) issued an announcement. Since Li Xinying has resigned, he will no longer act as an agent in legal proceedings, effective from March 26, 2024; and Tan Sihui has been appointed as an agent in legal proceedings, effective from March 26, 2024.
Financial Services Association Venture Capital Connect: In February, the domestic medical sector raised 4.1 billion yuan, down 42% month-on-month, with the highest amount of financing for innovative drugs
In February 2024, there were 80 private equity financing incidents in the domestic healthcare sector, a decrease of 27% from the previous month; the total amount of disclosed financing was about 4,066 billion yuan, a decrease of 42% from the previous month.
Elken Healthcare (01789.HK) held a board meeting on March 26 to consider and approve annual results
Gelonghui, Feb. 29 | Elken Healthcare (01789.HK) announced that the company will hold a board meeting on March 26, 2024 (Tuesday) at Room 1201, Tianyuan Xiangtai Building, No. 5 Anding Road, Chaoyang District, Beijing, China to consider and approve the Group's final results, proposed final dividend (if any), and handle any other matters for the year ended 31 December 2023.
AK MEDICAL: DATE OF BOARD MEETING
No Data